|
1
|
Tornesello ML, Duraturo ML, Losito S, et
al: Human papillomavirus genotypes and HPV 16 variants in penile
carcinoma. Int J Cancer. 122:132–137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gross G and Pfister H: Role of human
papillomavirus in penile cancer, penile intraepithelial squamous
cell neoplasias and in genital warts. Med Microbiol Immunol.
193:35–44. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Senba M, Mori N and Wada A: Oncogenesis
and the link between inflammation and cancer due to human
papillomavirus (HPV) infection, and the development of vaccine
control strategies. Cancer Res J. 2:307–338. 2009.
|
|
4
|
Munger K, Baldwin A, Edwards KM, et al:
Mechanisms of human papillomavirus-induced oncogenesis. J Virol.
78:11451–11460. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang HS, Postigo AA and Dean DC: Active
transcriptional repression by the Rb-E2F complex mediates G1 arrest
triggered by p16INK4a, TGFb, and contact inhibition.
Cell. 97:53–61. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sano T, Oyama T, Kashiwabara K, Fukuda T
and Nakajima T: Expression status of p16 protein is associated with
human papillomavirus oncogenic potential in cervical and genital
lesions. Am J Pathol. 153:1741–1748. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Klaes R, Friedrich T, Spitkovsky D, et al:
Overexpression of p16INK4a as a specific marker for
dysplastic and neoplastic epithelial cells of the cervix uteri. Int
J Cancer. 92:276–284. 2001.
|
|
8
|
Humbey O, Cairey-Remonnay S, Guerrini JS,
et al: Detection of the human papillomavirus and analysis of the
TP53 polymorphism of exon 4 at codon 72 in penile squamous cell
carcinoma. Eur J Cancer. 39:684–690. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferreux E, Lont AP, Horenblas S, et al:
Evidence for at least three alternative mechanisms targeting the
p16INK4a/cyclin D/Rb pathway in penile carcinoma, one of
which is mediated by high-risk human papillomavirus. J Pathol.
201:109–118. 2003.PubMed/NCBI
|
|
10
|
Prowse DM, Ktori EN, Chandrasekaran D,
Prapa A and Baithun S: Human papillomavirus-associated increase in
p16INK4a expression in penile lichen sclerosus and
squamous cell carcinoma. Br J Dermatol. 158:261–265.
2008.PubMed/NCBI
|
|
11
|
Sen R and Baltimore D: Inducibility of
kappa immunoglobulin enhancer-binding protein NF-kappa B by a
posttranslational mechanism. Cell. 47:921–928. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rothwarf DM, Zandi E, Natoli G and Karin
M: IKK-gamma is an essential regulatory subunit of the IkappaB
kinase complex. Nature. 395:297–300. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karin M and Greten FR: NF-κB: linking
inflammation and immunity to cancer development and progression.
Nat Rev Immunol. 5:749–759. 2005.
|
|
14
|
Karin M: Nuclear factor-κB in cancer
development and progression. Nature. 441:431–436. 2006.
|
|
15
|
Kiriakidis S, Andreakos E, Monaco C,
Foxwell B, Feldmann M and Paleolog E: VEGF expression in human
macrophages is NF-κB-dependent: studies using adenoviruses
expressing the endogenous NF-κB inhibitor IkkappaBalpha and a
kinase-defective form of the IkkappaB kinase 2. J Cell Sci.
116:665–674. 2003.
|
|
16
|
Senba M, Buziba N, Mori N, Wada A, Irie S
and Toriyama K: Detection of human papillomavirus and cellular
regulators p16INK4A, p53, and NF-κB in penile cancer
cases in Kenya. Acta Virol. 53:43–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Senba M, Mori N, Wada A, et al: Human
papillomavirus genotypes in penile cancers from Japanese patients
and HPV-induced NF-κB activation. Oncol Lett. 1:267–272.
2010.PubMed/NCBI
|
|
18
|
Senba M, Kumatori A, Fujita S, et al: The
prevalence of human papillomavirus genotypes in penile cancers from
northern Thailand. J Med Virol. 78:1341–1346. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Picconi MA, Eijan AM, Distefano AL, et al:
Human papillomavirus (HPV) DNA in penile carcinomas in Argentina:
analysis of primary tumors and lymph nodes. J Med Virol. 61:65–69.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cupp MR, Malek RS, Goellner JR, Smith TF
and Espy MJ: The detection of human papillomavirus deoxyribonucleic
acid in intraepithelial, in situ, verrucous and invasive carcinoma
of the penis. J Urol. 154:1024–1029. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sarkar FH, Miles BJ, Plieth DH and
Crissman JD: Detection of human papillomavirus in squamous neoplasm
of the penis. J Urol. 147:389–392. 1992.PubMed/NCBI
|
|
22
|
Tornesello ML, Buonaguro FM, Beth-Giraldo
E, Kyalwazi SK and Giraldo G: Human papillomavirus (HPV) DNA in
penile carcinomas and in two cell lines from high-incidence areas
for genital cancers in Africa. Int J Cancer. 51:587–592. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rubin MA, Kleter B, Zhou M, et al:
Detection and typing of human papillomavirus DNA in penile
carcinoma: evidence for multiple independent pathways of penile
carcinogenesis. Am J Pathol. 159:1211–1218. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cubilla AL, Reuter VE, Gregoire L, et al:
Basaloid squamous cell carcinoma: a distinctive human papilloma
virus-related penile neoplasm. A report of 20 cases. Am J Surg
Pathol. 22:755–761. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nguyen DX, Nguyen MM, Lee D, Griep AE and
Lambert PF: Human papillomavirus type 16 E7 maintains elevated
levels of the cdk25A tyrosine phosphatase during deregulation of
cell cycle arrest. J Virol. 77:619–632. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lam KY and Chan KW: Molecular pathology
and clinicopathologic features of penile tumors: with special
reference to analyses of p21 and p53 expression and unusual
histologic features. Arch Pathol Lab Med. 123:895–904.
1999.PubMed/NCBI
|
|
27
|
Lopes A, Bezerra AL, Pino CA, Serrano SV,
Mello CA and Villa LL: p53 as a new prognostic factor for lymph
node metastasis in penile carcinoma: analysis of 82 patients
treated with amputation and bilateral lymphadenectomy. J Urol.
168:81–86. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Milde-Langosch K, Riethdorf S,
Kraus-Poppinghaus A, Riethdorf L and Loning T: Expression of
cyclin-dependent kinase inhibitors p16MTS1,
p21WAF1, and p27KIP1 in HPV-positive and
HPV-negative cervical adenocarcinomas. Virch Arch. 439:55–61. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zielinski GD, Snijders PJ, Rozendaal L, et
al: The presence of high-risk HPV combined with specific p53 and
p16INK4a expression patterns points to high-risk HPV as
the main causative agent for adenocarcinoma in situ and
adenocarcinoma of the cervix. J Pathol. 201:535–543.
2003.PubMed/NCBI
|
|
30
|
Kalof AN, Evans MF, Simmons-Arnold L,
Beatty BG and Cooper K: p16INK4a immunoexpression and
HPV in situ hybridization signal patterns: potential markers of
high-grade cervical intraepithelial neoplasia. Am J Surg Pathol.
29:674–679. 2005.PubMed/NCBI
|
|
31
|
Dehn D, Torkko KC and Shroyer KR: Human
papillomavirus testing and molecular markers of cervical dysplasia
and carcinoma. Cancer. 111:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Naugler WE and Karin M: NF-κB and cancer –
identifying targets and mechanisms. Curr Opin Genet Dev. 18:19–26.
2008.
|
|
33
|
Nees M, Geoghegan JM, Hyman T, Frank S,
Miller L and Woodworth CD: Papillomavirus type 16 oncogenes
downregulate expression of interferon-responsive genes and
upregulate proliferation-associated and NF-κB-responsive genes in
cervical keratinocytes. J Virol. 75:4283–4296. 2001.PubMed/NCBI
|
|
34
|
Spitkovsky D, Hehner SP, Hofmann TG,
Moller A and Schmitz ML: The human papillomavirus oncoprotein E7
attenuates NF-κB activation by targeting IκB kinase complex. J Bio
Chem. 277:25576–25582. 2002.PubMed/NCBI
|
|
35
|
Havard L, Delvenne P, Frare P, Boniver J
and Giannini SL: Differential production of cytokines and
activation of NF-κB in HPV transformed keratinocytes. Virology.
298:271–285. 2002.
|
|
36
|
Havard L, Rahmouni S, Boniver J and
Delvenne P: High levels of p105 (NF-κB1) and p100 (NF-κB2) proteins
in HPV 16-transformed keratinocytes: role of E6 and E7
oncoproteins. Virology. 331:357–366. 2005.
|
|
37
|
Mishra A, Bharti AC, Varghese P, Saluja D
and Das BC: Differential expression and activation of NF-κB family
proteins during oral carcinogenesis: role of high risk human
papillomavirus infection. Int J Cancer. 119:2840–2850. 2006.
|
|
38
|
James MA, Lee JH and Klingelhutz AJ: Human
papillomavirus type 16 E6 activates NF-κB, induces cIAP-2
expression, and protects against apoptosis in a PDZ binding
motif-dependent manner. J Virol. 80:5301–5307. 2006.
|
